Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 9, Issue : 1, Year : 2022
Article Page : 53-57
https://doi.org/10.18231/j.ijpp.2022.010
Abstract
The present research work was carried out to evaluate the in-Vitro thrombolytic activity of a polyherbal formulation prepared by using extracts of different part of medicinal plants, having thrombolytic activity i.e. bulbs of cepa and seeds of The extracts had shown 38.93 % and 35.65 %, clot lysis activity respectively, that was significant with reference to Streptokinase (64.97 %) and water (1.26%). The formulated poly herbal formulation using these two extracts also had shown good thrombolytic activity. The phytochemical analysis of individul plant extract had shown presence of different phytochemicals in common. That indicates, the in-vitro thrombolytic activity of the plants may be due to the presence of these phytochemicals.
Keywords: Thrombolytic activity, Hydroalcoholic Plant extracts, Polyherbal syrup, Streptokinase, Thrombus
How to cite : Muduli A, Rout S K, Prusty A K, In-vitro thrombolytic activity study of a polyherbal formulation developed by using extracts of different medicinal plants. Indian J Pharm Pharmacol 2022;9(1):53-57
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.